ZymoGenetics, Inc. (ZGEN) CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move  
11/8/2010 7:48:09 AM

Xconomy -- Doug Williams, one of the few nationally prominent biotechnology executives in Seattle, has officially left his job as ZymoGenetics CEO now that the company’s $885 million takeover by Bristol-Myers Squibb has been completed, Xconomy has learned.